Cargando…

Advances in clinical chemistry. Vol. 53 /

Volume 53 in the internationally acclaimed Advances in Clinical Chemistry contains chapters submitted from leading experts from academia and clinical laboratory science. Authors are from a diverse field of clinical chemistry disciplines and diagnostics, ranging from basic biochemical exploration to...

Descripción completa

Detalles Bibliográficos
Clasificación:Libro Electrónico
Otros Autores: Makowski, Gregory S. (Gregory Stephen)
Formato: Electrónico eBook
Idioma:Inglés
Publicado: Amsterdam ; Boston : Elsevier/Academic Press, �2011.
Temas:
Acceso en línea:Texto completo

MARC

LEADER 00000cam a2200000Ia 4500
001 SCIDIR_ocn706130457
003 OCoLC
005 20231117044554.0
006 m o d
007 cr cnu---unuuu
008 110308s2011 ne a ob 001 0 eng d
040 |a N$T  |b eng  |e pn  |c N$T  |d OCLCQ  |d OPELS  |d OCLCQ  |d OCLCF  |d OCLCQ  |d DEBBG  |d D6H  |d LEAUB  |d OL$  |d UHL  |d OCLCO  |d OCLCQ  |d OCLCO 
020 |a 9780123858566  |q (electronic bk.) 
020 |a 0123858569  |q (electronic bk.) 
020 |a 9780123858559  |q (electronic bk.) 
020 |a 0123858550  |q (electronic bk.) 
035 |a (OCoLC)706130457 
050 4 |a RB40  |b .A38 vol. 53eb 
072 7 |a SCI  |x 013020  |2 bisacsh 
072 7 |a MED  |x 014000  |2 bisacsh 
082 0 4 |a 616.07/56  |2 22 
245 0 0 |a Advances in clinical chemistry.  |n Vol. 53 /  |c edited by Gregory S. Makowski. 
260 |a Amsterdam ;  |a Boston :  |b Elsevier/Academic Press,  |c �2011. 
300 |a 1 online resource (xiii, 184 pages) :  |b illustrations (some color) 
336 |a text  |b txt  |2 rdacontent 
337 |a computer  |b c  |2 rdamedia 
338 |a online resource  |b cr  |2 rdacarrier 
504 |a Includes bibliographical references and index. 
588 0 |a Print version record. 
520 |a Volume 53 in the internationally acclaimed Advances in Clinical Chemistry contains chapters submitted from leading experts from academia and clinical laboratory science. Authors are from a diverse field of clinical chemistry disciplines and diagnostics, ranging from basic biochemical exploration to cutting-edge microarray technology. Leading experts from academia and clinical laboratory science Volume emphasizes novel laboratory advances with application to clinical laboratory diagnostics and practical basic science studies. 
505 0 |a Front Cover; Advances in Clinical Chemistry; Copyright Page; Contents; Contributors; Preface; Chapter 1: Use of matrix-assisted laser desorption/ionization time-of-flight mass spectrometry for multiplex genotyping; 2. Introduction; 3. Genotyping Using Mass Spectrometry; 4. MALDI-TOF-MS; 5. Multiplex Genotyping by MALDI-TOF-MS; 6. Conclusions; References; Chapter 2: Rheumatic heart disease: Mediation by complex immune events; 2. Rheumatic Heart Disease; 3. Epidemiology; 4. Genetic Susceptibility; 5. Immune Mechanisms Involved in RHD; 6. Rheumatic Heart Disease Lesions; 7. Conclusions 
505 8 |a AcknowledgmentsReferences; Chapter 3: Dipeptidyl peptidase in autoimmune pathophysiology; 2. Introduction; 3. Molecular Aspects of CD26/DPPIV Role in Immunity; 4. Cellular Aspects of CD26/DPPIV Role in Immunity; 5. Clinical Aspects of CD26 Role in Immune Disorders; 6. Summary and Perspective; Acknowledgments; References; Chapter 4: Biochemistry of HELLP Syndrome; 2. Introduction; 3. Pathogenesis of HELLP and Preeclampsia: The Role of Placenta; 4. Inflammatory Response in HELLP Syndrome; 5. HELLP Syndrome, Complement Pathway, and the Coagulation System; 6. Conclusion; References 
505 8 |a Chapter 5: Homocysteine in Pregnancy2. Introduction; 3. Homocysteine Metabolism; 4. Prophylactic Folic Acid, Folate Status, and Homocysteine; 5. Choline and Homocysteine; 6. Nonnutritional Factors Associated with tHcy; 7. Health Benefits of tHcy Lowering; 8. Pregnancy; Acknowledgments; References; Chapter 6: Diabetes and tuberculosis: Analysis of a Paradox; 2. Introduction; 3. Definition of the Problem; 4. Analysis of Previous Experimental Results to Solve the Paradox; 5. Probable Difference in Glycation Patterns of Macrophage Proteins and Its Precursors 
505 8 |a 6. In Silico Analysis of the Possibility of Glycation-Induced Inhibition of NADPH Oxidase7. Solving the Paradox; Acknowledgment; References; Chapter 7: EGCG, green tea polyphenols and their synthetic analogs and prodrugs for human cancer prevention and treatment; 3. The Role of Tea Polyphenols in Carcinogenesis; 4. In Vitro and In Vivo Preclinical Studies on Tea Polyphenols; 5. Tea Polyphenols and Their Molecular Targets in Cancer Cells; 6. Tea Polyphenol Derivatives in Cancer Studies; 7. Conclusions; Acknowledgments; References; Index 
650 0 |a Clinical chemistry. 
650 2 |a Chemistry, Clinical  |0 (DNLM)D002624 
650 6 |a Chimie clinique.  |0 (CaQQLa)201-0016714 
650 7 |a SCIENCE  |x Chemistry  |x Clinical.  |2 bisacsh 
650 7 |a MEDICAL  |x Clinical Medicine.  |2 bisacsh 
650 7 |a Clinical chemistry  |2 fast  |0 (OCoLC)fst00864330 
700 1 |a Makowski, Gregory S.  |q (Gregory Stephen) 
776 0 8 |i Print version:  |t Advances in clinical chemistry. Vol. 53.  |d Amsterdam ; Boston : Elsevier/Academic Press, �2011  |z 9780123858559 
856 4 0 |u https://sciencedirect.uam.elogim.com/science/book/9780123858559  |z Texto completo